01:32 PM EST, 01/07/2025 (MT Newswires) -- Zomedica ( ZOM ) said Tuesday it struck a deal to market Cresilon's Vetigel hemostatic gel product line on an exclusive basis in the US and on a non-exclusive basis in other regions.

Under the license and supply agreement, Zomedica ( ZOM ) said it will assume responsibility for supplying US customers and will collaborate with Cresilon to support customers outside the country.

Vetigel is a plant-based formula to stop bleeding when applied to the source, the veterinary healthcare company said.